Brought to you by 
Auxilium and Bentley to develop testosterone gel
06 May 2002
Executive Summary
Drug delivery company Bentley Pharmaceuticals will license Auxilium A2 (start-up developing drugs for the aging population) rights to its permeation facilitator, CPE-215, to develop topical gel formulations of testosterone.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Auxilium and Bentley to develop testosterone gel
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice